Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19
A Randomized Clinical Trial
https://jamanetwork.com/journals/jama/fullarticle/2773108
A Randomized Clinical Trial
https://jamanetwork.com/journals/jama/fullarticle/2773108
Fluvoxamine public data repository
https://drive.google.com/drive/folders/1gAmzgoi_RW4Y3Cqd6I_O1X7goF3sNo0A
https://drive.google.com/drive/folders/1gAmzgoi_RW4Y3Cqd6I_O1X7goF3sNo0A
Media is too big
VIEW IN TELEGRAM
The Semmelweis Reflex: Pandemic Perspectives
May 10, 2021 OMA D11 Doctors' Lounge Event, featuring:
2:39 Steve Kirsch, CEO of the COVID-19 Early Treatment Fund, advocate for fluvoxamine.
19:01 Dr. Pierre Kory, ivermectin advocate, President and Chief Medical Officer of FLCCC.
36:46 Dr. Richard Neel MD, MPH, COL (Retd.) USAF, community physician, advocate for high dose melatonin, recently recognized by the Castroville, Texas COC as “Citizen of the Year” for helping to keep his fellow citizens out of hospitals during the pandemic. He has treated over 2000 COVID patients successfully in the community over the past year.
[source]
May 10, 2021 OMA D11 Doctors' Lounge Event, featuring:
2:39 Steve Kirsch, CEO of the COVID-19 Early Treatment Fund, advocate for fluvoxamine.
19:01 Dr. Pierre Kory, ivermectin advocate, President and Chief Medical Officer of FLCCC.
36:46 Dr. Richard Neel MD, MPH, COL (Retd.) USAF, community physician, advocate for high dose melatonin, recently recognized by the Castroville, Texas COC as “Citizen of the Year” for helping to keep his fellow citizens out of hospitals during the pandemic. He has treated over 2000 COVID patients successfully in the community over the past year.
[source]
This media is not supported in your browser
VIEW IN TELEGRAM
FDA Advisory Committee 10/26/2021:
"But, we're never going to learn about how safe this vaccine is unless we start giving it. That's just the way it goes." -Eric Rubin M.D. Editor New England Journal of Medicine
Does this sound like someone who cares about your children's health?
"But, we're never going to learn about how safe this vaccine is unless we start giving it. That's just the way it goes." -Eric Rubin M.D. Editor New England Journal of Medicine
Does this sound like someone who cares about your children's health?
Intriguing, proof-of-concept, randomized trial of a COVID treatment using oral blue light (n=31), with some favourable data points that will need reproduction at a larger size.
https://www.medrxiv.org/content/10.1101/2021.10.17.21265058v1
https://www.medrxiv.org/content/10.1101/2021.10.17.21265058v1
OSINT
Sigma 1 Receptor Agonist activity of SSRIs https://www.researchgate.net/publication/40728854_Sigma-1_Receptors_and_Selective_Serotonin_Reuptake_Inhibitors_Clinical_Implications_of_their_Relationship
Association between SSRI Antidepressant Use and Reduced Risk of Intubation or Death in Hospitalized Patients with Coronavirus Disease 2019: a Multicenter Retrospective Observational Study
https://www.medrxiv.org/content/10.1101/2020.07.09.20143339v2.full.pdf
https://www.medrxiv.org/content/10.1101/2020.07.09.20143339v2.full.pdf
OSINT
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7566888/
PubMed Central (PMC)
Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral…
Due to our interest in the chemical space of organic dyes to identify potential small-molecule inhibitors (SMIs) for protein-protein interactions (PPIs), we initiated a screen of such compounds to assess their inhibitory activity against the interaction ...